https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
This review aims to discuss the role of novel immunotherapies currently in development and their potential for use in the treatment of AL amyloidosis. This article is protected by copyright. All rights reserved.The objective of the present study was to develop a dosing algorithm for ciprofloxacin based on both renal function and pathogen susceptibility in critically ill patients. In this observational prospective multi-center pharmacokinetic study a total of 39 adult intensive care unit patients receiving ciprofloxacin were in